Milestone Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014
January 30, 2015 at 12:29 pm
Share
Milestone Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net loss of $696,776 against $442,109 a year ago. Net cash generated in operating activities was $77,844 against net cash used in operating activities of $774,230 a year ago. Purchase of equipment was $27,645 against $27,645 a year ago.
For the full year, the company reported net loss of $1,945,405 against $1,019,606 a year ago. Net cash used in operating activities was $829,345 against $2,828,524 a year ago.
Milestone Medical, Inc. develops epidural and intra-articular drug delivery systems based on patented, painless, computer-controlled injection and drug delivery technology. Its CompuFlo Epidural System provides anesthesiologists and other health care providers with the ability to determine and document the pressure at the needle tip in real-time. Its CompuFlo Epidural's DPS Dynamic Pressure Sensing Technology (DPS) allows the CompuFlo Epidural to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space. The DPS instrument is a patented computer-controlled injection system geared to the needs of the medical market. The Companyâs is also focused on marketing the Epidural medical and trainer instruments in the United States. The Companyâs products include medical instruments, handpieces/disposables, and other related products. It sells its products primarily through medical facilities and a global distribution network.
MILESTONE MEDICAL, INC. 
